NCT02255513View on ClinicalTrials.gov

A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

HLD200

DRUG

Placebo

Trial Locations (4)

27705

Duke University Medical Center, Durham

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

92660

AVIDA, Inc., Newport Beach

02050

South Shore Psychiatric Services, PC, Marshfield

Sponsors
All Listed Sponsors
lead

Ironshore Pharmaceuticals and Development, Inc

OTHER